Senti Biosciences
IPO
- Headquarters
- South San Francisco, California
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- sentibio.com
- Total Funding
- $205.6M
- Last Round
- $47.6M Corporate RoundDec 2024
About
Senti Biosciences is a clinical-stage biotechnology company developing next-generation cell and gene therapies using proprietary Gene Circuit technology. Founded in 2016 and headquartered in South San Francisco, California, Senti Bio programs synthetic biology logic gates into cells to create smarter medicines for oncology and other incurable diseases.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account